{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:46:22Z","timestamp":1785757582524,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.msard.2026.107039","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:13:20Z","timestamp":1769793200000},"page":"107039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Profiling peripheral blood oxidative stress in multiple sclerosis"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-997X","authenticated-orcid":false,"given":"Thomas","family":"Minton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Hares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J","family":"Scolding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107039_bib0021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2013.09.038","article-title":"Effects of fumaric acid esters on blood-brain barrier tight junction proteins","volume":"555","author":"B\u00e9nardais","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.msard.2026.107039_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120254","article-title":"Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro","volume":"10","author":"Brennan","year":"2015","journal-title":"PLoS. One"},{"issue":"47","key":"10.1016\/j.msard.2026.107039_bib0025","doi-asserted-by":"crossref","first-page":"77793","DOI":"10.18632\/oncotarget.12796","article-title":"Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer","volume":"7","author":"Cai","year":"2016","journal-title":"Oncotarget."},{"issue":"9","key":"10.1016\/j.msard.2026.107039_bib0038","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1083\/jcb.201704056","article-title":"A diacidic motif determines unconventional secretion of wild-type and ALS-linked mutant SOD1","volume":"216","author":"Cruz-Garcia","year":"2017","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.msard.2026.107039_bib0009","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.msard.2026.107039_bib0008","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awg038","article-title":"Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis","volume":"126","author":"Filippi","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2026.107039_bib0041","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.47588","article-title":"Serum neurofilament light and multiple sclerosis progression independent of acute inflammation","volume":"5","author":"Gafson","year":"2022","journal-title":"JAMa Netw. Open."},{"issue":"14","key":"10.1016\/j.msard.2026.107039_bib0020","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1177\/1352458517690617","article-title":"Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the phase 3 DEFINE and CONFIRM studies","volume":"23","author":"Gopal","year":"2017","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2026.107039_bib0004","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2008.08.035","article-title":"Elevated myeloperoxidase activity in white matter in multiple sclerosis","volume":"444","author":"Gray","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.msard.2026.107039_bib0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1750-3639.2007.00110.x","article-title":"Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis","volume":"18","author":"Gray","year":"2008","journal-title":"Brain Pathol."},{"issue":"Pt 7","key":"10.1016\/j.msard.2026.107039_bib0001","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107039_bib0037","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2023.05.022","article-title":"Human SOD1 is secreted via a conventional secretion pathway in Saccharomyces cerevisiae","volume":"666","author":"Hosomi","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.msard.2026.107039_bib0039","doi-asserted-by":"crossref","first-page":"8622","DOI":"10.1038\/s41467-024-52875-5","article-title":"Plekhg5 controls the unconventional secretion of Sod1 by presynaptic secretory autophagy","volume":"15","author":"Hutchings","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.msard.2026.107039_bib0003","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/bmm-2016-0097","article-title":"Oxidative stress-related biomarkers in multiple sclerosis: a review","volume":"10","author":"Ibitoye","year":"2016","journal-title":"Biomark. Med."},{"key":"10.1016\/j.msard.2026.107039_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577090","article-title":"Expression of LEP, LEPR and PGC1A genes is altered in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis","volume":"338","author":"Koli\u0107","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107039_bib0012","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diabetes.55.01.06.db05-0943","article-title":"Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells","volume":"55","author":"Kukidome","year":"2006","journal-title":"Diabetes"},{"issue":"Pt 3","key":"10.1016\/j.msard.2026.107039_bib0019","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2026.107039_bib0033","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10571-013-9944-5","article-title":"Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic","volume":"33","author":"Ljubisavljevic","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.msard.2026.107039_bib0007","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2026.107039_bib0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","article-title":"Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis","volume":"80","author":"Meier","year":"2023","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107039_bib0028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2377-14-58","article-title":"Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis","volume":"14","author":"Meyer-Moock","year":"2014","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2026.107039_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC. Bioinform.."},{"issue":"1","key":"10.1016\/j.msard.2026.107039_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.msard.2026.107039_bib0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s40478-014-0170-2","article-title":"Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis","volume":"2","author":"Nijland","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.msard.2026.107039_bib0031","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2015.04.010","article-title":"Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in Multiple Sclerosis patients","volume":"283","author":"Pasquali","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107039_bib0017","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2015.00204","article-title":"PGC-1\u03b1 silencing compounds the perturbation of mitochondrial function caused by mutant SOD1 in skeletal muscle of ALS mouse model","volume":"7","author":"Qi","year":"2015","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2026.107039_bib0036","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tcb.2016.11.007","article-title":"Pathways of unconventional protein secretion","volume":"27","author":"Rabouille","year":"2017","journal-title":"Trends. Cell Biol."},{"issue":"2","key":"10.1016\/j.msard.2026.107039_bib0027","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cmet.2013.12.014","article-title":"Endothelial PGC-1\u03b1 mediates vascular dysfunction in diabetes","volume":"19","author":"Sawada","year":"2014","journal-title":"Cell Metab."},{"issue":"Pt 7","key":"10.1016\/j.msard.2026.107039_bib0006","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awq118","article-title":"The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability","volume":"133","author":"Scalfari","year":"2010","journal-title":"Brain"},{"issue":"29","key":"10.1016\/j.msard.2026.107039_bib0013","doi-asserted-by":"crossref","first-page":"26597","DOI":"10.1074\/jbc.M301850200","article-title":"Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells","volume":"278","author":"St-Pierre","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.msard.2026.107039_bib0018","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.msard.2026.107039_bib0023","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2013.08.069","article-title":"Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis","volume":"554","author":"Szalardy","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.msard.2026.107039_bib0029","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"46","key":"10.1016\/j.msard.2026.107039_bib0035","doi-asserted-by":"crossref","first-page":"35554","DOI":"10.1074\/jbc.M607305200","article-title":"Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins","volume":"281","author":"Usatyuk","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.msard.2026.107039_bib0014","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.01.026","article-title":"PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells","volume":"66","author":"Valle","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.msard.2026.107039_bib0034","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1096\/fj.00-0881fje","article-title":"Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro","volume":"15","author":"Van der Goes","year":"2001","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"12","key":"10.1016\/j.msard.2026.107039_bib0002","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.freeradbiomed.2008.09.023","article-title":"Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression","volume":"45","author":"van Horssen","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.msard.2026.107039_bib0016","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbadis.2010.06.011","article-title":"Radical changes in multiple sclerosis pathogenesis","volume":"1812","author":"van Horssen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.msard.2026.107039_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.mito.2010.05.014","article-title":"Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?","volume":"10","author":"Witte","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.msard.2026.107039_bib0032","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fnins.2020.00823","article-title":"Oxidative stress marker aberrations in multiple sclerosis: a meta-analysis study","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.msard.2026.107039_bib0026","article-title":"The diagnostic value of peroxisome proliferator-activated receptor-\u03b3 coactivator-1\u03b1 in identifying different chronic heart failure phenotypes","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Cardiovasc. Med."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:04:15Z","timestamp":1785755055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"alternative-id":["S2211034826000751"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107039","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling peripheral blood oxidative stress in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107039"}}